Movember is proud to announce its latest prostate cancer investment of over $4.9 million. Eighteen grants (16 proposals and 2 ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

RedHill Biopharma (RDHL) announced the initiation of a Phase 2 clinical study to evaluate the efficacy of its opaganib candidate in combination ...

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study ...

The Mike Slive Foundation has named the recipients of six prostate cancer research grants. The grants are aimed at continuing the foundation’s stated mission ...

This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Actor Colin Egglesfield has been diagnosed with cancer for the third time in his life. The former "All My Children" star announced on Instagram on Jan. 20 he had been diagnosed with prostate ...

increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In April 2021, a provision in the 21st Century Cures act took effect which required that all medical test results ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

At least 800 men have shown signs and symptoms of prostate cancer during a health camp organised by the Buganda Kingdom and Kabaka Foundation at St. Joseph's Cathedral in Kyengera, raising ...